Literature DB >> 25376258

Cell-bound exopolysaccharides of Lactobacillus brevis KB290 enhance cytotoxic activity of mouse splenocytes.

E Sasaki1, S Suzuki, Y Fukui, N Yajima.   

Abstract

AIMS: This study aimed to identify the main active component of Lactobacillus brevis KB290 (KB290) that is responsible for enhanced cell-mediated cytotoxic activity of mouse splenocytes Live KB290, a probiotic strain derived from a Japanese traditional pickle, was previously reported to modulate innate immune responses as affecting on cell-mediated cytotoxic activity of mouse splenocytes. METHODS AND
RESULTS: We used live KB290, heat-killed KB290, a derivative strain (Lact. brevis KB392) with different amounts of cell-bound exopolysaccharide (EPS-b), and a crude extract of EPS-b from KB290 cell surface. Female BALB/c mice were fed a diet containing 10(10) CFU live KB290, 10(10) CFU live KB392, 15 mg heat-killed KB290 or 600 μg crude extract of EPS-b for 1 day. Live KB290 (P < 0.01), heat-killed KB290 (P < 0.05) and crude EPS-b at 600 μg (P < 0.05) per mouse significantly enhanced cytotoxic activity; however, live KB392 had no effect.
CONCLUSIONS: Both live and heat-killed KB290 and crude EPS-b significantly enhanced cytotoxic activity of mouse splenocytes. SIGNIFICANCE AND IMPACT OF THE STUDY: We demonstrated that EPS-b produced by KB290 has a critical role in enhancing cell-mediated cytotoxic activity in mouse spleen.
© 2014 The Society for Applied Microbiology.

Entities:  

Keywords:  Lactobacillus brevis KB290; Lactobacillus brevis KB392; cell-bound exopolysaccharides; cell-mediated cytotoxicity; heat-killed KB290

Mesh:

Substances:

Year:  2014        PMID: 25376258     DOI: 10.1111/jam.12686

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  4 in total

1.  Enterococcus casseliflavus KB1733 Isolated from a Traditional Japanese Pickle Induces Interferon-Lambda Production in Human Intestinal Epithelial Cells.

Authors:  Shohei Satomi; Daichi Kokubu; Takuro Inoue; Masaya Sugiyama; Masashi Mizokami; Shigenori Suzuki; Kazumoto Murata
Journal:  Microorganisms       Date:  2022-04-15

Review 2.  Harnessing the potential of Lactobacillus species for therapeutic delivery at the lumenal-mucosal interface.

Authors:  Joseph R Spangler; Julie C Caruana; Igor L Medintz; Scott A Walper
Journal:  Future Sci OA       Date:  2021-02-04

Review 3.  New lactic acid bacteria for skin health via oral intake of heat-killed or live cells.

Authors:  Hiromi Kimoto-Nira
Journal:  Anim Sci J       Date:  2018-04-26       Impact factor: 1.749

4.  Short Communication: Oral Administration of Heat-killed Lactobacillus brevis KB290 in Combination with Retinoic Acid Provides Protection against Influenza Virus Infection in Mice.

Authors:  Shohei Satomi; Sofia Khanum; Poppy Miller; Shigenori Suzuki; Hiroyuki Suganuma; Axel Heiser; Sandeep K Gupta
Journal:  Nutrients       Date:  2020-09-24       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.